{"DataElement":{"publicId":"7351600","version":"1","preferredName":"Prior Therapy Clinical Trial Eligibility Criteria Timing Wilms Tumor Category","preferredDefinition":"The question which asks for the category of prior chemotherapy administration in patients with a specific type of Wilms tumor.","longName":"PRI_CHEMTX_TIMG_WT_CTEC_CAT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"5778189","version":"1","preferredName":"Prior Therapeutic Procedure Or Radiation Therapy Administration Clinical Trial Eligibility Criteria","preferredDefinition":"Earlier in time or order._An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise._Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"3693401v1.0:5778187v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"3693401","version":"1","preferredName":"Prior Therapeutic Procedure","preferredDefinition":"Earlier in time or order.:An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C25629:C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D743B17B-E51D-394C-E040-BB89AD4312FF","latestVersionIndicator":"Yes","beginDate":"2013-03-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2013-03-06","modifiedBy":"ONEDATA","dateModified":"2013-03-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5778187","version":"1","preferredName":"Or Radiation Therapy Administration Clinical Trial Eligibility Criteria","preferredDefinition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.:The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.:Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"C37998:C15313:C25409:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D9BFCA4-B63F-66DC-E053-F662850A5F5E","latestVersionIndicator":"Yes","beginDate":"2017-04-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-04-20","modifiedBy":"ONEDATA","dateModified":"2017-04-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D9BFCA4-B650-66DC-E053-F662850A5F5E","latestVersionIndicator":"Yes","beginDate":"2017-04-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2017-04-20","modifiedBy":"TAYLORT","dateModified":"2018-11-08","changeDescription":"11/8/18 TT released/PClark. 10058 4/20/2017 LS/TT","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7351577","version":"1","preferredName":"Timing Chemotherapy Administration Wilms Tumor Category","preferredDefinition":"Category which describes the timing at which chemotherapy was administered during the course of management of Wilms tumor in a patient.","longName":"7351577v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"1000","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"3","valueDescription":"3","ValueMeaning":{"publicId":"7351578","version":"1","preferredName":"3","longName":"7351578","preferredDefinition":"Treatment consisting of vincristine/doxorubicin/cyclophosphamide initiated on an emergent basis and within allowed timing as described in Section 3.1.5.1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA59575E-D61D-61A0-E053-4EBD850AADDA","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"GALITG","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA59575E-D636-61A0-E053-4EBD850AADDA","beginDate":"2020-07-13","endDate":null,"createdBy":"GALITG","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"2","valueDescription":"2","ValueMeaning":{"publicId":"7351579","version":"1","preferredName":"2","longName":"7351579","preferredDefinition":"Patient received no more than 6 weeks of chemotherapy following upfront nephrectomy or biopsy for presumed focal anaplastic Wilms tumor or favorable histology Wilms tumor based on institutional review, which was subsequently corrected to diffuse anaplastic Wilms tumor based on the AREN03B2 initial risk assignment results.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA59575E-D640-61A0-E053-4EBD850AADDA","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"GALITG","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA59575E-D659-61A0-E053-4EBD850AADDA","beginDate":"2020-07-13","endDate":null,"createdBy":"GALITG","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"},{"value":"1","valueDescription":"1","ValueMeaning":{"publicId":"7351580","version":"1","preferredName":"1","longName":"7351580","preferredDefinition":"Patient received no more than 12 weeks of pre-nephrectomy chemotherapy for what was originally presumed to be focal anaplastic Wilms tumor or favorable histology Wilms tumor but was subsequently confirmed to be diffuse anaplastic Wilms tumor at delayed nephrectomy.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA59575E-D663-61A0-E053-4EBD850AADDA","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"GALITG","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AA59575E-D67C-61A0-E053-4EBD850AADDA","beginDate":"2020-07-13","endDate":null,"createdBy":"GALITG","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008525","version":"1","preferredName":"Eligibility","preferredDefinition":"trial-specific criteria that a patient must meet to be enrolled.","longName":"ELIG","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1EC3968-9F25-305A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7351576","version":"1","preferredName":"Timing Chemotherapy Administration Wilms Tumor Category","preferredDefinition":"The chronological relationship between temporal events.:The use of synthetic or naturally-occurring chemicals for the treatment of diseases.:The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.:An embryonal neoplasm characterized by the presence of epithelial, mesenchymal, and blastema components. The vast majority of cases arise from the kidney. A small number of cases with morphologic features resembling Wilms tumor of the kidney have been reported arising from the ovary and the cervix.:A grouping of items based on some commonality or by user defined characteristics.","longName":"7351576v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Timing","conceptCode":"C80484","definition":"The chronological relationship between temporal events.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Wilms Tumor","conceptCode":"C3267","definition":"An embryonal neoplasm characterized by the presence of epithelial, mesenchymal, and blastema components. The vast majority of cases arise from the kidney. A small number of cases with morphologic features resembling Wilms tumor of the kidney have been reported arising from the ovary and the cervix.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA59575E-D5F6-61A0-E053-4EBD850AADDA","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"GALITG","dateCreated":"2020-07-13","modifiedBy":"ONEDATA","dateModified":"2020-07-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA59575E-D607-61A0-E053-4EBD850AADDA","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"GALITG","dateCreated":"2020-07-13","modifiedBy":"GALITG","dateModified":"2020-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If Yes, which criteria did th","type":"Preferred Question Text","description":"If Yes, which criteria did the subject meet?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AA5905E6-302C-1B77-E053-4EBD850A8896","latestVersionIndicator":"Yes","beginDate":"2020-07-13","endDate":null,"createdBy":"GALITG","dateCreated":"2020-07-13","modifiedBy":"GALITG","dateModified":"2020-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}